Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: systematic review and meta-analysis
- PMID: 25899581
- DOI: 10.1530/EJE-14-0911
Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: systematic review and meta-analysis
Abstract
Objective: The aim of this study was to perform a systematic review and meta-analysis on insulin resistance in adult patients with type 1 diabetes mellitus compared to healthy controls, assessed by hyperinsulinemic euglycemic clamp studies.
Design and methods: We conducted a systematic search of publications using PubMed, EMBASE, Web of Science and COCHRANE Library. Hyperinsulinemic euglycemic clamp studies comparing adult patients with type 1 diabetes mellitus to healthy controls were eligible. Primary outcome measures were pooled mean differences of insulin sensitivity of endogenous glucose production (EGP), of glucose uptake and of lipolysis. We estimated mean (standardized) differences and 95% CIs using random effects meta-analysis.
Results: We included 38 publications in this meta-analysis. The weighed mean differences in EGP during hyperinsulinemia between patients and controls was 0.88 (95% CI: 0.47, 1.29) in the basal state and 0.52 (95% CI: 0.09, 0.95) in insulin stimulated conditions, indicating decreased hepatic insulin sensitivity in patients. Insulin sensitivity of glucose uptake was either reported as M value (M), glucose infusion rate (GIR), glucose disposal rate (GDR) or metabolic clearance rate (MCR). Weighed mean differences were similar for M -3.98 (95% CI: -4.68, -3.29) and GIR -4.61 (95% CI: -5.86, -3.53). Weighed mean difference for GDR was -2.43 (95% CI: -3.03, -1.83) and -3.29 (95% CI: -5.37, -1.22) for MCR, indicating decreased peripheral insulin sensitivity in patients. Insulin mediated inhibition of lipolysis was decreased in patients, reflected by increased non-esterified fatty acid levels.
Conclusions: Insulin resistance is a prominent feature of patients with type 1 diabetes mellitus and involves hepatic, peripheral and adipose tissues.
© 2015 European Society of Endocrinology.
Similar articles
-
Continuous glucose monitoring systems for type 1 diabetes mellitus.Cochrane Database Syst Rev. 2012 Jan 18;1(1):CD008101. doi: 10.1002/14651858.CD008101.pub2. Cochrane Database Syst Rev. 2012. PMID: 22258980 Free PMC article.
-
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD009966. doi: 10.1002/14651858.CD009966.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jul 30;8:CD009966. doi: 10.1002/14651858.CD009966.pub3. PMID: 28238223 Free PMC article. Updated.
-
Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies.Hum Reprod. 2016 Nov;31(11):2619-2631. doi: 10.1093/humrep/dew243. Epub 2016 Oct 7. Hum Reprod. 2016. PMID: 27907900
-
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.Cochrane Database Syst Rev. 2016 Jun 7;2016(6):CD005542. doi: 10.1002/14651858.CD005542.pub3. Cochrane Database Syst Rev. 2016. PMID: 27272351 Free PMC article.
-
Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.Cochrane Database Syst Rev. 2017 Jun 11;6(6):CD009613. doi: 10.1002/14651858.CD009613.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 May 23;5:CD009613. doi: 10.1002/14651858.CD009613.pub4. PMID: 28602020 Free PMC article. Updated.
Cited by
-
CD3+CD56+ T Lymphocytes Are Associated With ER Stress and Inflammasome Activation in Type 1 Diabetes.In Vivo. 2022 Sep-Oct;36(5):2083-2091. doi: 10.21873/invivo.12934. In Vivo. 2022. Retraction in: In Vivo. 2024 Jul-Aug;38(4):2097. doi: 10.21873/invivo.13670. PMID: 36099092 Free PMC article. Retracted.
-
Correlation between triglyceride-glucose index and diabetic kidney disease risk in adults with type 1 diabetes mellitus.Diabetol Metab Syndr. 2024 Oct 1;16(1):239. doi: 10.1186/s13098-024-01468-9. Diabetol Metab Syndr. 2024. PMID: 39354589 Free PMC article.
-
HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives.Diabetologia. 2024 Feb;67(2):290-300. doi: 10.1007/s00125-023-06034-y. Epub 2023 Nov 2. Diabetologia. 2024. PMID: 37914981 Free PMC article.
-
Insulin sensitivity estimates and their longitudinal association with coronary artery disease in type 1 diabetes. Does it matter?Cardiovasc Diabetol. 2024 May 3;23(1):152. doi: 10.1186/s12933-024-02234-x. Cardiovasc Diabetol. 2024. PMID: 38702680 Free PMC article.
-
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance.Endocr Rev. 2025 May 9;46(3):317-348. doi: 10.1210/endrev/bnae032. Endocr Rev. 2025. PMID: 39998445 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical